It’s the first time the experimental treatment, which has previously only been shown to tackle biofilms in mice, has also worked in pigs, a large animal with lungs that are similar in size, structure and immune response to human lungs.
It’s also the first time the treatment has been shown to be administrable through a nebulizer, the same type of medical device human patients would use. Breathing in the “living medicine” thinned the biofilm inside breathing tubes from 6.08 to 3.67 micrometers, reducing thickness by around 40%.